Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Annie Huang

Physician Assistant, Medical Pasadena, CA Physician Assistant

NPI 1508036617 CMS profile 10498613

55 E California Blvd Fl 3, Pasadena, CA 91105

Open in the dashboard

General payments

$11,961

483 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Annie Huang of Pasadena, CA is reported in the CMS Open Payments database as having received $11,961 across 483 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,745 74
2024 General $4,336 132
2023 General $2,113 89
2022 General $1,996 100
2021 General $1,771 88

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Annie Huang
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Annie Huang were reported at $1,745. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Annie Huang Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $1,771 $156 $41–$563 $132
2022 $1,996 $185 $55–$649 $149
2023 $2,113 $199 $58–$717 $160
2024 $4,336 $206 $62–$740 $164
2025 $1,745 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $1,893 28 payments
  2. Novartis Pharmaceuticals Corporation $1,648 88 payments
  3. Abbott Laboratories $1,029 42 payments
  4. AstraZeneca Pharmaceuticals LP $869 50 payments
  5. Amgen Inc. $865 50 payments
  6. Pfizer Inc. $754 37 payments
  7. Merck Sharp & Dohme Corporation $675 27 payments
  8. Boehringer Ingelheim Pharmaceuticals, Inc. $669 29 payments
  9. Esperion Therapeutics, Inc. $566 20 payments
  10. Alnylam Pharmaceuticals Inc. $467 16 payments
  11. Other $2,526 96 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $10,778 476 payments
  2. Travel and Lodging $971 4 payments
  3. Consulting Fee $175 1 payment
  4. Education $37 2 payments
Products named General payments · program years 2021–2025
  1. WATCHMAN FLX $1,559 15 payments
  2. LEQVIO Cardiology/Vascular Diseases $926 51 payments
  3. VERQUVO $906 37 payments
  4. Repatha $757 45 payments
  5. ELIQUIS $754 37 payments
  6. NEXLETOL $566 20 payments
  7. FARXIGA $562 34 payments
  8. ENTRESTO $527 27 payments
  9. JARDIANCE $382 16 payments
  10. LEQVIO Cardiovascular $376 19 payments
  11. Other $5,836 235 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

483 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record